Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
25-27 August, 2025
CBL & RAB BiocontrolCBL & RAB Biocontrol
Not Confirmed
Not Confirmed
27-28 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
25-27 August, 2025
CBL & RAB BiocontrolCBL & RAB Biocontrol
Industry Trade Show
Not Confirmed
27-28 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
21 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250821182068/en/European-Commission-Approves-Tablet-Formulation-of-BeOne-Medicines-BRUKINSA-for-All-Approved-Indications
31 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250731014937/en/BeOne-Medicines-Receives-PRIME-Designation-from-the-European-Medicines-Agency-for-BGB-16673-in-Waldenstroms-Macroglobulinemia
28 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250728331235/en/BeOne-Medicines-Receives-Positive-CHMP-Opinion-for-TEVIMBRA-in-NeoadjuvantAdjuvant-NSCLC-Treatment
16 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250716492641/en/BeOne-Medicines-to-Announce-Second-Quarter-2025-Financial-Results-on-August-6
10 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250710356913/en/European-Commission-Approves-TEVIMBRA-in-Combination-with-Chemotherapy-as-a-First-Line-Treatment-for-Nasopharyngeal-Carcinoma
09 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250709188805/en/Biocytogen-Enters-into-Antibody-Licensing-Agreement-with-BeOne-Medicines-to-Accelerate-Innovative-Drug-Development
Data currently not available.
Ask PharmaCompass should you need more information on this topic.
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : TEVIMBRA
Dosage Strength : 10 mg/mL
Packaging :
Approval Date :
Application Number : 761380
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Australia
Dosage Form :
Brand Name : Tevimbra
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Dosage Form :
Brand Name : Tevimbra
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Norway
Dosage Form : Concentrate for infusion...
Brand Name : Tevimbra
Dosage Strength : 100 mg
Packaging : Vials 1 10ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTION;SOLUTION
Brand Name : TEVIMBRA
Dosage Strength : 100MG/10ML
Packaging :
Approval Date :
Application Number : 761232
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INTRAVENOUS
Brand Name : TEVIMBRA
Dosage Strength : 100MG/10ML(10MG/ML)
Packaging :
Approval Date :
Application Number : 761417
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : BRUKINSA
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number : 2512963
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Australia
Dosage Form :
Brand Name : Brukinsa
Dosage Strength :
Packaging : 120
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Dosage Form :
Brand Name : Brukinsa
Dosage Strength :
Packaging : 120
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Switzerland
Dosage Form : Caps
Brand Name : Brukinsa
Dosage Strength : 80mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Norway
Dosage Form : Concentrate for infusion solut...
Dosage Strength : 100 mg
Packaging : Vials 1 10ml
Brand Name : Tevimbra
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Dosage Form : Caps
Dosage Strength : 80mg
Packaging :
Brand Name : Brukinsa
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
ABOUT THIS PAGE